Detailed Information

Cited 0 time in webofscience Cited 0 time in scopus
Metadata Downloads

Ophthalmic complications in retinopathy of prematurity in the first decade of life in Korea using the national health insurance database

Full metadata record
DC Field Value Language
dc.contributor.authorHong, Eun Hee-
dc.contributor.authorShin, Yong Un-
dc.contributor.authorBae, Gi Hwan-
dc.contributor.authorChoi, Young Jin-
dc.contributor.authorAhn, Seong Joon-
dc.contributor.authorKim, Inah-
dc.contributor.authorCho, Heeyoon-
dc.date.accessioned2022-07-06T10:37:12Z-
dc.date.available2022-07-06T10:37:12Z-
dc.date.created2022-03-07-
dc.date.issued2022-01-
dc.identifier.issn2045-2322-
dc.identifier.urihttps://scholarworks.bwise.kr/hanyang/handle/2021.sw.hanyang/139768-
dc.description.abstractThe aim of this study is to investigate the epidemiology of ophthalmic complications of retinopathy of prematurity (ROP) after preterm birth using population-based database in South Korea. Using the National Health Insurance database, ophthalmic complications among premature infants born in 2007-2008 during their 10-year follow-up period were identified. Annual cumulative incidence rate and period prevalence of complications at each age were analyzed among those with ROP and those who underwent treatment for ROP (tROP). The hazard ratios (HRs) according to the presence of ROP and treatment for ROP were also analyzed. We identified 18,256 premature infants, 6995 of whom had ROP. The prevalence at 10th year for overall ophthalmic complications was 11.1% and 35.9% among ROP and tROP, respectively. Strabismus, amblyopia, and glaucoma were the three most common complications. The presence of ROP was associated with higher risk of complications (HR 1.53, 95%CI 1.44-1.61) among premature infants, and the presence of treatment for ROP was associated with higher risk of complications (HR 4.31, 95%CI 3.74-4.98) among ROP cases. This study reports the nationwide epidemiologic data on ophthalmic complications of ROP during the first decade of life, which will help advance our understandings and establish national strategies in managing ROP.-
dc.language영어-
dc.language.isoen-
dc.publisherNATURE RESEARCH-
dc.titleOphthalmic complications in retinopathy of prematurity in the first decade of life in Korea using the national health insurance database-
dc.typeArticle-
dc.contributor.affiliatedAuthorShin, Yong Un-
dc.contributor.affiliatedAuthorAhn, Seong Joon-
dc.contributor.affiliatedAuthorKim, Inah-
dc.contributor.affiliatedAuthorCho, Heeyoon-
dc.identifier.doi10.1038/s41598-021-04616-7-
dc.identifier.scopusid2-s2.0-85123071310-
dc.identifier.wosid000744120000017-
dc.identifier.bibliographicCitationSCIENTIFIC REPORTS, v.12, no.1, pp.1 - 8-
dc.relation.isPartOfSCIENTIFIC REPORTS-
dc.citation.titleSCIENTIFIC REPORTS-
dc.citation.volume12-
dc.citation.number1-
dc.citation.startPage1-
dc.citation.endPage8-
dc.type.rimsART-
dc.type.docTypeArticle-
dc.description.journalClass1-
dc.description.isOpenAccessY-
dc.description.journalRegisteredClassscie-
dc.description.journalRegisteredClassscopus-
dc.relation.journalResearchAreaScience & Technology - Other Topics-
dc.relation.journalWebOfScienceCategoryMultidisciplinary Sciences-
dc.subject.keywordPlusAGE 6 YEARS-
dc.subject.keywordPlusFOLLOW-UP-
dc.subject.keywordPlusTHRESHOLD RETINOPATHY-
dc.subject.keywordPlusREFRACTIVE STATUS-
dc.subject.keywordPlusPRETERM INFANTS-
dc.subject.keywordPlusSTRABISMUS-
dc.subject.keywordPlusPREVALENCE-
dc.subject.keywordPlusCHILDREN-
dc.subject.keywordPlusAMBLYOPIA-
dc.subject.keywordPlusGLAUCOMA-
dc.identifier.urlhttps://www.nature.com/articles/s41598-021-04616-7-
Files in This Item
Appears in
Collections
서울 의과대학 > 서울 직업환경의학교실 > 1. Journal Articles
서울 의과대학 > 서울 안과학교실 > 1. Journal Articles

qrcode

Items in ScholarWorks are protected by copyright, with all rights reserved, unless otherwise indicated.

Related Researcher

Researcher Kim, Inah photo

Kim, Inah
COLLEGE OF MEDICINE (DEPARTMENT OF OCCUPATIONAL AND ENVIRONMENTAL MEDICINE)
Read more

Altmetrics

Total Views & Downloads

BROWSE